Add to ORKGThis is a protocol to describe the methodology for a systematic review of clinical trials registries to identify intervention trials in the treatment of CF and map them to priorities for CF research
The purpose of this protocol is to set out the aims, objectives and commitments of the Cystic Fibros...
Introduction:Cystic fibrosis (CF) is a multisystem disorder. Treatment is complex and evidence for t...
Cystic fibrosis (CF), the most common life-shortening genetic disorder in Caucasians, affects approx...
This is a protocol to describe the methodology for a systematic review of clinical trials registries...
The review aims to identify current clinical trials on cystic fibrosis treatments and to find out ho...
There are many uncertainties regarding Cystic Fibrosis (CF) treatment. Recently, the first James Lin...
This is a protocol which sets out the aims, objectives and commitments of the second phase of the Ja...
This is a protocol which sets out the aims, objectives and commitments of the second phase of the Ja...
There remain many treatment uncertainties in cystic fibrosis (CF). With limited resources, research ...
There remain many treatment uncertainties in cystic fibrosis (CF). With limited resources, research ...
In a recent James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF) the top priorit...
In a collaboration between health professionals and the patient community, we previously identified ...
There remain many treatment uncertainties in cystic fibrosis (CF). With limited resources, research ...
In 2018 we published the James Lind Alliance (JLA) top 10 priorities for clinical research in cystic...
The purpose of this protocol is to set out the aims, objectives and commitments of the Cystic Fibros...
The purpose of this protocol is to set out the aims, objectives and commitments of the Cystic Fibros...
Introduction:Cystic fibrosis (CF) is a multisystem disorder. Treatment is complex and evidence for t...
Cystic fibrosis (CF), the most common life-shortening genetic disorder in Caucasians, affects approx...
This is a protocol to describe the methodology for a systematic review of clinical trials registries...
The review aims to identify current clinical trials on cystic fibrosis treatments and to find out ho...
There are many uncertainties regarding Cystic Fibrosis (CF) treatment. Recently, the first James Lin...
This is a protocol which sets out the aims, objectives and commitments of the second phase of the Ja...
This is a protocol which sets out the aims, objectives and commitments of the second phase of the Ja...
There remain many treatment uncertainties in cystic fibrosis (CF). With limited resources, research ...
There remain many treatment uncertainties in cystic fibrosis (CF). With limited resources, research ...
In a recent James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF) the top priorit...
In a collaboration between health professionals and the patient community, we previously identified ...
There remain many treatment uncertainties in cystic fibrosis (CF). With limited resources, research ...
In 2018 we published the James Lind Alliance (JLA) top 10 priorities for clinical research in cystic...
The purpose of this protocol is to set out the aims, objectives and commitments of the Cystic Fibros...
The purpose of this protocol is to set out the aims, objectives and commitments of the Cystic Fibros...
Introduction:Cystic fibrosis (CF) is a multisystem disorder. Treatment is complex and evidence for t...
Cystic fibrosis (CF), the most common life-shortening genetic disorder in Caucasians, affects approx...